You are here

Researchers and Physicians

Fall 2018 Breakthroughs Message From The Director

At Duke Cancer Institute, inspired by the bravery of our patients, we don’t shrink from even the most daunting challenges. We tackle them head-on.

DCI Authorized To Offer Commercial CAR-T Cell Therapy

In January 2018, Duke Cancer Institute joined a select group of medical centers authorized to offer a new type of immunotherapy for patients with certain types of relapsed or refractory non-Hodgkin’s lymphoma. Duke is currently one of two centers in the Carolinas and Virginia that are certified and...

The Bladder Guy

BRANT INMAN, MD, MS , is skilled at the major sur­geries that no one wants to be unlucky enough to have. “I’m the guy who when you’ve got a tumor this big, you call to take it out,” says Inman, holding his hands up in the shape of a grapefruit. “Yesterday I removed two bladders and replaced them.”...

Stealing Time From Urologic Cancer

DAN GEORGE, MD, remem­bers one of the first times he helped someone live longer. He was treating a patient with metastatic kidney can­cer who enrolled in a clinical trial of a new drug and was one of the first people in the United States to receive it. “He could only tolerate the drug for about...

Spring 2018 Breakthroughs Message From The Director

Ten years, twelve years, even more than two decades. That is how long some of Duke Cancer Institute’s patients with prostate and other urologic cancers are liv­ing past their diagnoses, thanks to a new generation of therapies and our physician-scientists’ willing­ness to leave no avenue unpursued...

The Toxic Cost Of Cancer

FUMIKO CHINO, MD , a resident in radiation oncology, last summer co-authored research showing that the high cost of cancer care is a serious problem for many patients. But for Chino, this problem—“financial toxicity”—is more than just academic. In 2005, she was engaged to be married and was working...

What Does Heart Disease Have To Do With Cancer?

In 2017, Chiara Melloni, MD, a cardiologist and researcher at Duke Clinical Research Institute, and colleagues published results of one of the first studies to look at management of patients with both cancer and atrial fibrillation (a type of irregular heartbeat). The study may not have happened if...

Amplifying The Patient Voice

It’s something that has happened to all of us; you arrive on time for your 10:30 a.m. doctor’s appointment and wait an hour, only to have the doctor spend 15 minutes with you. Doctors are busy people. THOMAS LEBLANC, MD , is no different, but early in his career as a medical student, he took...

#MyDukeCancerStory: Passion for Bacteria Eradication Drives Cancer Researcher

Meira Epplein, PhD, MS, MA, can hardly recall a time when she wasn’t thinking about what she now considers her “life’s work” — researching Helicobacter pylori , the primary identified cause of stomach cancer. The path to getting there, she says, “was a bit unusual.” A co-leader for Duke Cancer...

Pages